| ABBOTT LABORATORIES (ABT) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 | |
| Balance Sheet Date | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 | 2014-Jun-30 | 2014-Mar-31 | 2013-Dec-31 | |
| Fiscal Period | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | Q3-FY2014 | Q2-FY2014 | Q1-FY2014 | Q4-FY2013 | |
| Price to Sales | 5.65x | 6.10x | 6.29x | 5.43x | 5.37x | 5.50x | 5.08x | 4.89x | 5.45x | 4.82x | 5.38x | 4.24x | 4.99x | 4.27x | 4.74x | 4.69x | 6.48x | 5.54x | 5.72x | 5.68x | 6.27x | 6.69x | 5.76x | 4.34x | 5.38x | 5.27x | 5.34x | 4.57x | 4.15x | 4.23x | 3.62x | 3.68x | 3.63x | 3.69x | |||||||||||||||
| Price to Book | 4.86x | 5.25x | 5.37x | 4.71x | 4.73x | 5.70x | 5.26x | 5.08x | 5.67x | 5.13x | 5.83x | 4.75x | 5.94x | 5.39x | 5.92x | 5.90x | 7.79x | 6.80x | 6.80x | 6.32x | 6.62x | 6.87x | 5.92x | 4.61x | 5.53x | 5.20x | 5.21x | 4.54x | 4.16x | 4.19x | 3.50x | 3.33x | 3.22x | 2.90x | |||||||||||||||
| Price to Earnings | 17.87x | 19.30x | 19.59x | 17.23x | 17.00x | 39.88x | 37.46x | 35.28x | 38.36x | 37.42x | 42.13x | 30.44x | 31.57x | 24.46x | 25.36x | 27.14x | 39.63x | 32.48x | 36.23x | 37.27x | 48.55x | 64.08x | 58.54x | 39.14x | 46.85x | 50.55x | 57.42x | 53.86x | 53.95x | 147.26x | 116.89x | 224.64x | 212.48x | 44.33x | |||||||||||||||
| Price to Unlevered FCF | 35.79x | 38.65x | 40.05x | 34.56x | 35.47x | 34.98x | 36.56x | 40.05x | 43.24x | 42.84x | 39.47x | 25.79x | 27.94x | 22.50x | 25.52x | 25.62x | 32.27x | 25.15x | 26.60x | 27.90x | 37.93x | 47.01x | 39.67x | 31.12x | 38.19x | 43.35x | 40.33x | 31.55x | 25.89x | 26.25x | 22.21x | 21.08x | 22.42x | 23.24x | |||||||||||||||
| Debt to Asset Ratio | .39x | .39x | .40x | .41x | .46x | .46x | .46x | .47x | .48x | .49x | .50x | .50x | .51x | .51x | .52x | .52x | .53x | .54x | .54x | .55x | .54x | .55x | .54x | .54x | .53x | .53x | .54x | .54x | .57x | .55x | .55x | .59x | .55x | .55x | .55x | .61x | .47x | .48x | .47x | .48x | .49x | .48x | .49x | .47x | .46x | .43x | .44x | .41x | |
| Current Ratio | 1.70x | 1.82x | 1.78x | 1.67x | 1.60x | 1.68x | 1.60x | 1.64x | 1.74x | 1.64x | 1.68x | 1.63x | 1.86x | 2.01x | 1.85x | 1.85x | 1.83x | 1.79x | 1.75x | 1.72x | 1.70x | 1.57x | 1.43x | 1.44x | 1.54x | 1.68x | 1.58x | 1.62x | 1.42x | 1.58x | 1.66x | 2.26x | 2.69x | 2.94x | 2.91x | 4.02x | 1.56x | 1.50x | 1.48x | 1.54x | 1.82x | 2.30x | 2.17x | 1.30x | 1.52x | 1.85x | 1.76x | 2.02x | |